Literature DB >> 15545520

Enhanced arteriogenesis and wound repair in dystrophin-deficient mdx mice.

Stefania Straino1, Antonia Germani, Anna Di Carlo, Daniele Porcelli, Roberta De Mori, Antonella Mangoni, Monica Napolitano, Fabio Martelli, Paolo Biglioli, Maurizio C Capogrossi.   

Abstract

BACKGROUND: The absence of functional dystrophin in Duchenne muscular dystrophy (DMD) patients and in mdx mice results in progressive muscle degeneration associated with necrosis, fibrosis, and inflammation. Because vascular supply plays a key role in tissue repair, we examined whether new blood vessel development was altered in mdx mice. METHODS AND
RESULTS: In a model of hindlimb ischemia on femoral artery dissection, hindlimb perfusion, measured by laser Doppler imaging, was higher in mdx mice (0.67+/-0.26) than in wild-type (WT) mice (0.33+/-0.18, P<0.03). In keeping with these data, a significant increase in arteriole length density was found in mdx mice (13.6+/-8.4 mm/mm3) compared with WT mice (7.8+/-4.6 mm/mm3, P<0.03). Conversely, no difference was observed in capillary density between mice of the 2 genotypes. The enhanced regenerative response was not limited to ischemic skeletal muscle, because in a wound-healing assay, mdx mice showed an accelerated wound closure rate compared with WT mice. Moreover, a vascularization assay in Matrigel plugs containing basic fibroblast growth factor injected subcutaneously revealed an increased length density of arterioles in mdx (46.9+/-14.7 mm/mm3) versus WT mice (19.5+/-5.8 mm/mm3, P<0.001). Finally, serum derived from mdx mice sustained formation of endothelium-derived tubular structures in vitro more efficiently than WT serum.
CONCLUSIONS: These results demonstrate that arteriogenesis is enhanced in mdx mice both after ischemia and skin wounding and in response to growth factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15545520     DOI: 10.1161/01.CIR.0000147776.50787.74

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

Review 1.  The interaction of coronary tone and cardiac fibrosis.

Authors:  Matthew T Wheeler; Elizabeth M McNally
Journal:  Curr Atheroscler Rep       Date:  2005-05       Impact factor: 5.113

2.  Detrimental effect of class-selective histone deacetylase inhibitors during tissue regeneration following hindlimb ischemia.

Authors:  Francesco Spallotta; Silvia Tardivo; Simona Nanni; Jessica D Rosati; Stefania Straino; Antonello Mai; Matteo Vecellio; Sergio Valente; Maurizio C Capogrossi; Antonella Farsetti; Julie Martone; Irene Bozzoni; Alfredo Pontecorvi; Carlo Gaetano; Claudia Colussi
Journal:  J Biol Chem       Date:  2013-07-07       Impact factor: 5.157

3.  Cooperation of endothelial and smooth muscle cells derived from human induced pluripotent stem cells enhances neovascularization in dermal wounds.

Authors:  Koung Li Kim; Sun-Hwa Song; Kyu-Sil Choi; Wonhee Suh
Journal:  Tissue Eng Part A       Date:  2013-07-27       Impact factor: 3.845

4.  Combination of stromal cell-derived factor-1 and collagen-glycosaminoglycan scaffold delays contraction and accelerates reepithelialization of dermal wounds in wild-type mice.

Authors:  Aparajita Sarkar; Soner Tatlidede; Saja Sandra Scherer; Dennis P Orgill; François Berthiaume
Journal:  Wound Repair Regen       Date:  2010-12-06       Impact factor: 3.617

5.  Delayed bone regeneration is linked to chronic inflammation in murine muscular dystrophy.

Authors:  Rana Abou-Khalil; Frank Yang; Marie Mortreux; Shirley Lieu; Yan-Yiu Yu; Maud Wurmser; Catia Pereira; Frédéric Relaix; Theodore Miclau; Ralph S Marcucio; Céline Colnot
Journal:  J Bone Miner Res       Date:  2014-02       Impact factor: 6.741

6.  Adaptive and nonadaptive responses to voluntary wheel running by mdx mice.

Authors:  Rachel M Landisch; Allison M Kosir; Steven A Nelson; Kristen A Baltgalvis; Dawn A Lowe
Journal:  Muscle Nerve       Date:  2008-10       Impact factor: 3.217

7.  Circulating microRNAs are new and sensitive biomarkers of myocardial infarction.

Authors:  Yuri D'Alessandra; Paolo Devanna; Federica Limana; Stefania Straino; Anna Di Carlo; Paola G Brambilla; Mara Rubino; Maria Cristina Carena; Liana Spazzafumo; Marco De Simone; Barbara Micheli; Paolo Biglioli; Felice Achilli; Fabio Martelli; Stefano Maggiolini; Giancarlo Marenzi; Giulio Pompilio; Maurizio C Capogrossi
Journal:  Eur Heart J       Date:  2010-06-09       Impact factor: 29.983

Review 8.  Mesenchymal stem cells: emerging therapy for Duchenne muscular dystrophy.

Authors:  Chad D Markert; Anthony Atala; Jennifer K Cann; George Christ; Mark Furth; Fabrisia Ambrosio; Martin K Childers
Journal:  PM R       Date:  2009-06       Impact factor: 2.298

9.  Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.

Authors:  Ju Lan Chun; Robert O'Brien; Min Ho Song; Blake F Wondrasch; Suzanne E Berry
Journal:  Stem Cells Transl Med       Date:  2012-12-27       Impact factor: 6.940

10.  Blastocyst injection of wild type embryonic stem cells induces global corrections in mdx mice.

Authors:  Elizabeth Stillwell; Joseph Vitale; Qingshi Zhao; Amanda Beck; Joel Schneider; Farah Khadim; Genie Elson; Aneela Altaf; Ghassan Yehia; Jia-hui Dong; Jing Liu; Willie Mark; Mantu Bhaumik; Robert Grange; Diego Fraidenraich
Journal:  PLoS One       Date:  2009-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.